Cargando…

Atorvastatin reduces serum HMGB1 levels in patients with hyperlipidemia

High mobility group box 1 protein (HMGB1) has been identified as a novel pro-inflammatory cytokine in coronary artery disease. This study investigated the effect of atorvastatin on serum HMGB1 levels in patients with hyperlipidemia. In 72 patients with hyperlipidemia, serum total cholesterol (TC), t...

Descripción completa

Detalles Bibliográficos
Autores principales:	JIN, DAOQUN, WU, YONGBO, ZHAO, LIN, GUO, JIE, ZHANG, KAI, CHEN, ZHIQIANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494102/ https://www.ncbi.nlm.nih.gov/pubmed/23226786 http://dx.doi.org/10.3892/etm.2012.732

Ejemplares similares

Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia
por: Huang, Congwu, et al.
Publicado: (2014)

Metabonomics Study of the Therapeutic Mechanism of Gynostemma pentaphyllum and Atorvastatin for Hyperlipidemia in Rats
por: Wang, Miao, et al.
Publicado: (2013)

A comparative effect of atorvastatin with other statins in patients of hyperlipidemia
por: Jose, M. Alvin, et al.
Publicado: (2012)

Effectiveness of Coelatura aegyptiaca Extract Combination with Atorvastatin on Experimentally Induced Hyperlipidemia in Rats
por: Mohamed, Ayman Saber, et al.
Publicado: (2019)

Omega-3 Fatty Acid Based Nanolipid Formulation of Atorvastatin for Treating Hyperlipidemia
por: Sreedhar, Revathy, et al.
Publicado: (2019)

Comparison of Dietary Control and Atorvastatin on High Fat Diet Induced Hepatic Steatosis and Hyperlipidemia in Rats
por: Ji, Guiyuan, et al.
Publicado: (2011)

TRAF1 Exacerbates Myocardial Ischemia Reperfusion Injury via ASK1–JNK/p38 Signaling
por: Xu, Weipan, et al.
Publicado: (2019)

Correlation of serum HMGB1 and HMGB2 levels with clinical symptoms in allergic rhinitis children
por: Xing, Xinxin, et al.
Publicado: (2023)

Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
por: Sivkov, Andrey, et al.
Publicado: (2021)

Atorvastatin associated with gamma glutamyl transpeptidase elevation in a hyperlipidemia patient: A case report and literature review
por: Xu, Yan, et al.
Publicado: (2020)

Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome
por: Manganelli, Valeria, et al.
Publicado: (2017)

Atorvastatin Treatment for Atrial Fibrillation Reduces Serum High-Sensitivity C-Reactive Protein Levels
por: Su, Fang-Cheng, et al.
Publicado: (2015)

Associations between serum leptin levels, hyperlipidemia, and cholelithiasis in dogs
por: Lee, Sungin, et al.
Publicado: (2017)

Effect of tadalafil combined with atorvastatin on hemodynamics and sexual function in middle-aged and elderly patients with hyperlipidemia complicated with erectile dysfunction
por: Du, Lei, et al.
Publicado: (2021)

The significance of serum HMGB1 level in humans with acute paraquat poisoning
por: Chen, Feng, et al.
Publicado: (2019)

Serum HMGB1 level is correlated with serum I-FABP level in neonatal patients with necrotizing enterocolitis
por: Huo, Ruyahan, et al.
Publicado: (2021)

Association of ABCB1 (C3435T) and ABCC1 (G2012T) Polymorphisms with Clinical Response to Atorvastatin in Iranian Patients with Primary Hyperlipidemia
por: Behdad, Niusha, et al.
Publicado: (2017)

Atorvastatin Ester Regulates Lipid Metabolism in Hyperlipidemia Rats via the PPAR-signaling Pathway and HMGCR Expression in the Liver
por: Hu, Nan, et al.
Publicado: (2021)

Multiparticulate Systems of Ezetimibe Micellar System and Atorvastatin Solid Dispersion Efficacy of Low-Dose Ezetimibe/Atorvastatin on High-Fat Diet-Induced Hyperlipidemia and Hepatic Steatosis in Diabetic Rats
por: Torrado-Salmerón, Carlos, et al.
Publicado: (2021)

Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis
por: Zheng, Ji-Na, et al.
Publicado: (2020)

Atorvastatin Combining with Probucol: A New Way to Reduce Serum Uric Acid Level during Perioperative Period of Interventional Procedure
por: Li, Hong, et al.
Publicado: (2014)

Inhibiting HMGB1 Reduces Cerebral Ischemia Reperfusion Injury in Diabetic Mice
por: Wang, Chong, et al.
Publicado: (2016)

Efficacy of different doses of atorvastatin treatment on serum levels of 8-hydroxy-guanin (8-OHdG) and cardiac function in patients with ischemic cardiomyopathy
por: Jin, Yu, et al.
Publicado: (2015)

Anti-hyperlipidemia of garlic by reducing the level of total cholesterol and low-density lipoprotein: A meta-analysis
por: Sun, Yue-E, et al.
Publicado: (2018)

Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas
por: Lee, Hanna, et al.
Publicado: (2012)

Effects of Reducing the South and Reinforcing the North Method on Inflammatory Injury Induced by Hyperlipidemia
por: Wu, Hongjin, et al.
Publicado: (2021)

Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer
por: Su, Qingchang, et al.
Publicado: (2023)

FiberCreme as a Functional Food Ingredient Reduces Hyperlipidemia and Risk of Cardiovascular Diseases in Subjects with Hyperlipidemia
por: Sunarti,, et al.
Publicado: (2022)

A comparative study of efficacy of atorvastatin alone and its combination with fenofibrate on lipid profile in type 2 diabetes mellitus patients with hyperlipidemia
por: Lella, Meenakshi, et al.
Publicado: (2013)

Alteration of serum high-mobility group protein 1 (HMGB1) levels in children with enterovirus 71-induced hand, foot, and mouth disease
por: Zheng, Weikun, et al.
Publicado: (2017)

Atorvastatin Reduces Plasma Levels of Chemokine (CXCL10) in Patients with Crohn's Disease
por: Grip, Olof, et al.
Publicado: (2009)

Atorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells
por: Wu, ShangJie, et al.
Publicado: (2005)

Serum and urine ANGPTL8 expression levels are associated with hyperlipidemia and proteinuria in primary nephrotic syndrome
por: Li, Yue, et al.
Publicado: (2021)

Changes in Homocysteine Levels Affect Serum Lipid Response to Atorvastatin in Patients With Acute Coronary Syndrome: A Retrospective Observational Study
por: Wu, Dong-Feng, et al.
Publicado: (2020)

Dietary Supplementation with Hazelnut Oil Reduces Serum Hyperlipidemia and Ameliorates the Progression of Nonalcoholic Fatty Liver Disease in Hamsters Fed a High-Cholesterol Diet
por: Lu, Jen-Her, et al.
Publicado: (2019)

Is serum HMGB1 a biomarker in ANCA-associated vasculitis?
por: de Souza, Alexandre Wagner Silva, et al.
Publicado: (2013)

HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
por: Chen, Mingkun, et al.
Publicado: (2021)

Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome
por: Palmblad, Karin, et al.
Publicado: (2021)

Serum levels of NLRP3 and HMGB-1 are associated with the prognosis of patients with severe blunt abdominal trauma
por: Sun, Kuanxue, et al.
Publicado: (2019)

Atorvastatin lowers serum calcium levels in lithium-users: results from a randomized controlled trial
por: Soh, Jocelyn Fotso, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f22eben6llcq963d9snomv2466